News

Search For News


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

Search results for {{term}}

1. Vivasure Medical Announces €16.2M ($18.3M) in Financing to Advance Com

Vivasure Medical Announces €16.2M ($18.3M) in Financing to Advance Commercialization of Closure Device in European Union and United States 08/09/2016Vivasure Medical™, a company developing a novel bioabsorbable technology for percutaneous vessel closure, today announced that the company has completed a Series C financing of €16.2M ($18.3M). The round was led by LSP (Life Sciences Partners) of The Netherlands, investing from its LSP Health Economics Fund, and co-led by Evon


2. Emma Walmsley to Succeed Andrew Witty as Chief Executive Officer of Gl

Emma Walmsley to Succeed Andrew Witty as Chief Executive Officer of GlaxoSmithKline 20/09/2016GSK today announces that Emma Walmsley, currently Chief Executive Officer (CEO) of GSK’s Consumer Healthcare division, is appointed GSK CEO Designate and will succeed Andrew Witty as GSK CEO, when he retires on 31March 2017. Emma will join the GSK Board of Directors from 1 January 2017.Emma is currently CEO of GSK Consumer Healthcare, one of the world’s largest consumer health companies


3. MD Anderson Cancer Center and Adaptimmune Form Strategic Alliance to A

MD Anderson Cancer Center and Adaptimmune Form Strategic Alliance to Advance Development of Immunotherapies Targeting Multiple Cancers 26/09/2016Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, and The University of Texas MD Anderson Cancer Center announced today that they have entered into a multi-year strategic alliance designed to expedite the development of novel adoptive T-cell therapies for multiple types of cancer.The alliance pairs MD Anderson&


4. Atlantic Healthcare Appoints Karl Keegan as Chief Financial Officer

Atlantic Healthcare Appoints Karl Keegan as Chief Financial Officer 29/09/2016Atlantic Healthcare plc, an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI) disorders, today announces the appointment of Karl Keegan, as Chief Financial Officer.Prior to joining Atlantic Healthcare, Karl gained significant experience in the UK, European and U.S. healthcare markets working in senior positions at a number of private and publicly listed companies and leading


5. Launch of Carrick Therapeutics Signals New Approach to Cancer Therapie

Launch of Carrick Therapeutics Signals New Approach to Cancer Therapies. $95m Initial Funding from Leading Investor Syndicate03/10/2016Carrick Therapeutics Ltd, a unique new venture in cancer treatment, launched today having secured $95M in funding. It brings together world-class cancer researchers and drug development experts, backed by some of the most eminent providers of early stage capital, with the aim of building Europe's leading oncology company.Carrick Therapeutics has research and deve



Page 16 of 30 ( 148 results in total )
© Catalyst Innovation Portal 2018